Yahoo Finance • 11 months ago
Improved confidence in the supply chains ability to support strong demand in the aircraft industry has led to a positive outlook for Boeing (NYSE:BA). RBC Capital Markets analyst Ken Herbert has increased the price target for Boeing to $27... Full story
Yahoo Finance • 2 years ago
MASON, Ohio, February 17, 2023--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today an... Full story
Yahoo Finance • 2 years ago
MASON, Ohio, November 01, 2022--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain managem... Full story
Yahoo Finance • 2 years ago
It might be of some concern to shareholders to see the AtriCure, Inc. (NASDAQ:ATRC) share price down 15% in the last month. Looking further back, the stock has generated good profits over five years. It has returned a market beating 72% in... Full story
Yahoo Finance • 2 years ago
MASON, Ohio, July 12, 2022--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management... Full story
Yahoo Finance • 2 years ago
AtriCure, Inc. (NASDAQ:ATRC), might not be a large cap stock, but it saw significant share price movement during recent months on the NASDAQGM, rising to highs of US$66.36 and falling to the lows of US$35.10. Some share price movements can... Full story
Yahoo Finance • 3 years ago
MASON, Ohio, May 03, 2022--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management,... Full story